CDC requests OMB approval to implement minor changes to the Screening and Assessment MDE and the Intervention MDE. No changes to the Progress Report are proposed. The program scope, purpose, burden, protocol, methodology, and planned analyses remain unchanged from the previous approval.
The purpose of the WISEWOMAN program is to reduce cardiovascular disease (CVD) risk factors among at-risk women. CDC collects evaluation information from grantees semi-annually, including data about the risk factors of women served, the interventions in which they participated, and program cost and progress information. The women served through the WISEWOMAN program also participate in the National Breast and Cervical Cancer Early Detection Program.
PL:
Pub.L. 101 - 354 300n-4a
Name of Law: The Breast and Cervical Cancer Mortality Prevention Act of 1990
US Code:
42 USC 301
Name of Law: Public Health Service Act
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.